Clinical Trial Update: Liposomal Bupivacaine in One-level Instrumented Posterior Spinal Fusion [Phase 4]

View source ↗

Summary

A Phase 4 trial of liposomal bupivacaine in a one-level instrumented posterior spinal fusion has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Disc Disease
• Lumbar Disc Herniation
• Lumbar Spinal Stenosis
• Lumbar Spondylolisthesis

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: Allina Health System | Conditions: Lumbar Spinal Stenosis, Lumbar Disc Herniation | Phase 4 | Status: SUSPENDED